DEXUS (ASX:DXS) Could Be 22% Below Fair Value After APAC Appeal Update
Dexus (ASX:DXS) has updated investors on the APAC legal case, with the Court setting October 20, 2026 for hearings on the REST and Dexus Bloc appeals, and multiple cross appeals and contentions now filed.
See our latest analysis for DEXUS.
At a share price of A$5.76, Dexus has seen short term share price gains, including a 1-day share price return of 1.59% and 7-day share price return of 2.67%. Its year to date share price performance is weaker and longer term total shareholder returns over 1, 3 and 5 years have been negative. This suggests recent momentum is building from a lower base as investors weigh ongoing legal and broader business developments.
If you are reassessing your real asset exposure after this Dexus update, it can help to widen the lens and look at companies exposed to long term infrastructure and power demand via 33 power grid technology and infrastructure stocks
After Dexus’s recent share price bump and ongoing APAC legal overhang, the key issue now is whether current levels still compensate you for those risks, or whether the better risk reward was available at lower prices.
Most Popular Narrative: 21.6% Undervalued
On the latest close, Dexus at A$5.76 sits meaningfully below the most widely followed fair value estimate of A$7.35, which is built from detailed earnings and cash flow expectations.
Portfolio repositioning and targeted capital recycling into high-growth sectors and precincts
especially premium-grade office assets in core CBDs and modern industrial facilities
are expected to drive higher-margin revenues and resilient earnings, as evidenced by record leasing, rising re-leasing spreads, and positive valuation trends in H2 FY25.
Want to understand why this Dexus valuation leans higher than the current price? The core of the narrative is a reshaped portfolio, richer margins, and a future profit profile that assumes a meaningfully stronger earnings base and a higher earnings multiple than today.
Result: Fair Value of A$7.35 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the Dexus story could shift quickly if office demand weakens further, or if APAC fund redemptions and litigation escalate and pressure fees and planned asset sales.
Find out about the key risks to this DEXUS narrative.
Next Steps
Given the mix of concern around risks and optimism about potential rewards at Dexus, it makes sense to move quickly, review the data, and shape your own view with the help of 4 key rewards and 2 important warning signs
Looking for more investment ideas beyond Dexus?
If Dexus has you thinking more broadly about where to put your capital to work, now is the moment to scan for other quality setups using Simply Wall St’s tools.
- Target potential mispricings by reviewing companies that screen as promising on valuation and quality through the 9 high quality undervalued stocks
- Strengthen your core holdings by checking stocks that appear resilient on debt and cash metrics in the solid balance sheet and fundamentals stocks screener (20 results)
- Spot underfollowed opportunities early by running your eye over the screener containing 12 high quality undiscovered gems
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com